Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide ...

Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRIin patients with uncontrolled asthma published in The Lancet Respiratory Medicine Full results from the ...

(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere. Shares in the Cambridge, England-based pharmaceutical company rose ...

WILMINGTON - AstraZeneca’s BREZTRI Aerosphere demonstrated statistically significant improvements in lung function for patients with uncontrolled asthma compared to dual-combination therapies, ...

BANGKOK - The Thai Food and Drug Administration (FDA) has warned consumers about an unauthorised popular-brand 2g herbal inhaler after finding it was using another product’s drug registration number.

What fits in the overhead bin today may not tomorrow, according to a warning that has travelers rethinking how much confidence they can place in carry-on labels. In the clip, Schaler said that, “so ...

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved AstraZeneca's Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF ...

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall ...

Astrazeneca (AZN) reported $15.5 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.1%. EPS of $1.06 for the same period compares to $2.10 a year ago.

One of the most exciting events in the winter Olympics is ice hockey. This is likely because it is the sport that fans see more often throughout the year and are most familiar with. It is also the ...